F. Charlotte et al., IMMUNOHISTOCHEMICAL DETECTION OF BCL-2 PROTEIN IN NORMAL AND PATHOLOGICAL HUMAN LIVER, The American journal of pathology, 144(3), 1994, pp. 460-465
The bcl-2 protein, which prolongs cell survival by blocking apoptosis,
is expressed by progenitor cells in several self-renewing tissues and
by tumoral cells in some extrahepatic neoplasms. Because the liver is
a slow self-renewing tissue, an immunohistochemical study of the cell
ular distribution of the bcl-2 protein was performed in normal liver (
12 cases), nontumoral hepatic lesions (33 cases), and benign or malign
ant liver tumors (46 cases). In normal liver, bcl-2 was expressed by b
ile ductules and small bile duct epithelium, but not by hepatocytes or
large bile duct epithelium. lit cirrhosis and focal nodular hyperplas
ia, epithelial cells of the ductular proliferation were bcl-2-positive
. Eight of II cholangiocarcinomas stained positively for bcl-2, wherea
s all 15 hepatocellular carcinomas were bcl-2-negative. bcl-2 was also
expressed in 6 of 14 metastatic adenocarcinomas. These findings sugge
st that the ductular cells and small bile duct epithelial cells might
have a prolonged survival and might be hepatic progenitor cells. In ad
dition, the bcl-2-protein appears to be a marker of cholangiocarcinoma
but not of hepatocellular carcinoma and could help in distinguishing
between these two primary liver tumors.